Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.
AqVida Oncology
FOLLOW
AqVida is a pharmaceutical company with focus on the development, registration and supply of generic oncology products and biosimilars. Some of AqVidas finished products like Paclitaxel, Docetaxel or Oxaliplatin have considerable market share in Germany and the company is involved in new development projects in the oncology sector. The products are offered under the AqVida brand or under their partners` brands in the EU and less regulated markets.
As a pharmaceutical company AqVida offers you all needed competencies from API sourcing up to EU market release for finished products, but aim to keep complexity low, the ethos is: A direct line internal as well as external gives us the opportunity to react and move fast.
Experts in development, regulatory affairs, patent issues and laboratory work together closely to get out the best for AqVida`s clients as well as for their suppliers.
The company has also built a pool of sales knowledge concerning international market conditions and registration conditions. Depending on clients needs, AqVida accompanies from development to successful launch.
AqVida’s quality management system conforms to all German and EU legal requirements for the pharmaceutical industry (i.e. AMG, AMWHV and EU-GMP) and is GMP certified by the German Health Authorities.
Their in-house laboratory provides the infrastructure to allow their qualified team to conduct analytics and quality control according to strict quality management processes. Their strong supplier qualification system assures the provision of EU-GMP compliant APIs and finished medicinal products.
AqVida’s manufacturing license applies to the EU-batch control analysis and the EU-market release of pharmaceutical products. The AqVida laboratory conducts batch analysis as well as releases to markets according to all respective European standards. All processes comply with European GMP.
Aqvida differentiate their business models for their clients including API supply, dossiers for registration and development purposes, technology transfers up to registered and released products for the European market.
They are also developing portfolio, marketing and sales strategies together with their clients.
Together with pharmaceutical manufacturers whose destination is Europe Aqvida work on optimising processes and quality standards to match the required criterias for the European market. They also run registration procedures and can multiply your registration in several EU countries.
AqVida GmbH
Kaiser-Wilhelm-Str 89
D-20355
Hamburg
Germany
Phone: +49 40 380371 90
Fax: +49 40 38071 92
Web: www.aqvida.com